Latest Competition News

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.

IDT Australia Limited reported a strong 40.6% increase in revenue to $19.86 million for FY25, driven by growth in advanced therapies and contract disbursements. However, the company’s net loss widened to $8.06 million as it transitions from its ‘Rebuild Strategy’ to a new phase focused on sustainable profitability.

Po Valley Energy and its partners have inked a 12-month gas sales agreement with Hera Trading, marking a strategic shift from BP Gas Marketing and reinforcing local ties in Italy’s energy sector.

Netwealth Group Limited reported robust FY25 results, with Funds Under Administration soaring to $112.8 billion and net profit after tax climbing nearly 40%, underpinned by strong operational leverage and strategic investments.

Peter Warren Automotive Holdings reported a steady FY25 underlying profit before tax of $22.3 million, maintaining revenue despite a challenging new car market and declaring a final dividend. The group’s strategic focus on cost control, inventory discipline, and acquisitions underpinned its resilience.

Netwealth Group Limited has reported a stellar FY25 with record funds under administration net flows of $15.8 billion and a 31% rise in EBITDA, underpinned by strong adviser growth and strategic technology investments.

Pengana International Equities Limited (ASX, PIA) proposes a strategic portfolio enhancement by adding global private credit exposure, aiming to significantly lift fully franked dividends and diversify income streams.

EQT Holdings Limited reported a robust FY25 with a 60% jump in net profit and record funds under management, while completing a major acquisition integration and raising dividends.

Redox Limited reported a 9.4% increase in FY25 revenue to $1.244 billion driven by volume growth and strategic acquisitions, while profits declined amid inflationary pressures. The company declared a final dividend of 6.5 cents per share and maintains zero net debt.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Redox Ltd reported a robust 9.4% increase in revenue for FY25, supported by strong volume growth and three strategic acquisitions, despite margin compression and a challenging macroeconomic backdrop.

Pengana International Equities reported a solid $33.8 million profit for FY2025 and unveiled a strategic plan to diversify into global private credit, aiming to increase dividends by over half and shift to monthly payments.